AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionDaymark Wealth Partners, Llc
Latest Disclosed Ownership84,689 shares
Latest Disclosed Value $ 18,419,023
Daymark Wealth Partners, Llc reports 0.64% decrease in ownership of 4AB / AbbVie Inc.

On May 11, 2026 - Daymark Wealth Partners, Llc filed a 13F-HR form disclosing ownership of 84,689 shares of AbbVie Inc. (BG:4AB) valued at $18,419,023 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 85,234 shares of AbbVie Inc.. This represents a change in shares of -0.64% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 84,689 -545 -0.64 18,419 -5.42 0.5793
2026-01-12 2025-12-31 13F ABBVIE COM 00287Y109 85,234 96 0.11 19,475 -1.20 0.6205
2025-10-22 2025-09-30 13F ABBVIE COM 00287Y109 85,138 3,324 4.06 19,713 29.80 0.6692
2025-08-04 2025-06-30 13F ABBVIE COM 00287Y109 81,814 2,276 2.86 15,186 -8.87 0.5777
2025-04-23 2025-03-31 13F/A-1 ABBVIE COM 00287Y109 79,538 1,145 1.46 16,665 19.63 0.7161
2025-04-14 2025-03-31 13F ABBVIE COM 00287Y109 79,538 1,145 16,665 0.7186
2025-01-17 2024-12-31 13F/A-1 ABBVIE COM 00287Y109 78,393 -807 -1.02 13,930 -10.93 0.5887
2025-01-17 2024-12-31 13F ABBVIE COM 00287Y109 78,393 -807 13,930 0.5887
2024-10-08 2024-09-30 13F ABBVIE COM 00287Y109 79,200 2,452 3.19 15,640 18.82 0.6621
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 76,748 33,981 79.46 13,164 69.04 0.6039
2024-04-10 2024-03-31 13F ABBVIE COM 00287Y109 42,767 -260 -0.60 7,788 16.80 0.4191
2024-01-09 2023-12-31 13F ABBVIE COM 00287Y109 43,027 -4,008 -8.52 6,668 -4.91 0.4095
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 47,035 6,153 15.05 7,011 27.29 0.4829
2023-07-19 2023-06-30 13F ABBVIE COM 00287Y109 40,882 5,394 15.20 5,508 -2.60 0.4091
2023-04-20 2023-03-31 13F ABBVIE COM 00287Y109 35,488 3,655 11.48 5,656 9.93 0.7504
2023-01-25 2022-12-31 13F ABBVIE COM 00287Y109 31,833 31,833 5,145 0.9101
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.